Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40557
First IPO Date
August 07, 1998
| Name | Title | Pay | Year Born |
| Wang Xingli | Co-President & CEO of the Innovative Drugs Business Unit | 0 | 1962 |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Yi Liu | President, CEO, Co-Chair of the Innov Drugs, Chair, CEO of the Diag & Therap Tech & Exec Director | 0 | 1975 |
| Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division | 0 | 1967 |
| Deyong Wen | Executive Vice Chairman | 9.14M | 1971 |
| Yuqing Chen | Executive Chairman | 12.14M | 1975 |
| Xiaohui Guan | Executive Co-Chairman | 15.25M | 1971 |
| Donghua Wang | Senior Vice President | 0 | 1969 |
| Zhanyu Chen | Senior Vice President & Chief Financial Officer | 0 | 1972 |
| Jingzhu Cai | VP, Chief Investment Officer & GM of Global Strategic Investment Department | 0 | N/A |
| Mei Ha Kam FCIS | Joint Company Secretary | 0 | 1968 |
| Zhi Huang | Senior VP, CFO & Co-President of the Innovative Drugs Business Unit | 0 | N/A |
| Yue Zhu | Vice President & GM of Legal Department | 0 | 1977 |
| Kexin Wang | Executive Director | 0 | 1965 |
| Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a prominent entity in the pharmaceutical sector, engaged in the research, production, and marketing of medicinal products. Its operations extend across Mainland China and into international territories. The company's multifaceted business structure is divided into five core divisions: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, and Other Business activities. Fosun's pharmaceutical offerings are primarily directed towards therapeutic solutions for oncology, immune system disorders, metabolic diseases, digestive health, and central nervous system conditions. Beyond drug development, the firm also supplies medical equipment and diagnostic instruments. Furthermore, it provides healthcare services, encompassing the management of hospitals. The company's comprehensive scope also includes the wholesale and retail distribution of medicines. Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is headquartered in Shanghai, China.